Nicorette^® Transdermal Patch 15 mg

• Each patch contains NICOTINE equivalent to 1,75 mg per 1,0 cm2.  

• The dose administered is determined by the size of contact area of the system. 

Used as part of a smoking cessation programme as a temporary aid to the cigarette smoker seeking to give up the smoking habit.

Constant release of nicotine over 16 hours.

Adults and the Elderly

• The patch should be applied to an intact area of the skin upon waking up in the morning and removed at bedtime. Patch treatment mimics the fluctuations of nicotine over the day in smokers, with no nicotine administration during sleep. Daytime nicotine patch treatment does not give the nicotine induced sleep disturbances seen with nicotine administration during sleep. 

• Heavy smokers are recommended to start at Step 1 with the 25 mg/ 16 hours patch and use one patch daily for 8 weeks. 

• Gradual weaning from the patch should then be initiated. One 15 mg/16 hours patch should be used daily for 2 weeks followed by one 10 mg/16 hours patch daily for 2 weeks. 

• Light smokers are recommended to start at Step 2 (15 mg) for 8 weeks and decrease the dose to Step 3 (10 mg) for the final 4 weeks

Size: 7s

S1 Nicorette^® Transdermal Patch 15 mg: Each patch contains nicotine equivalent to 1,75 mg per 1,0 cm2. Content of NICOTINE per patch 23,62 mg. Reg. No. 45/32.16/0953.

For full prescribing information, refer to the Professional Information approved by the medicines regulatory authority.

ZA-NI-2400012